Muromonab-CD3

Betascript PublishingEAN 9786133024533

108,10 €

Günstigster Gesamtpreis bei averdo.com

Kostenloser VersandLieferzeit: 2 Tage

Preisvergleich 2 Angebote verfügbar

ShopsVersand
averdo.comGünstigster Gesamtpreis
Muromonab-CD3
108,10 €
KostenlosLieferzeit: 2 Tage
108,10 €
Günstigster Gesamtpreis
Kostenloser Versand
Lieferzeit: 2 Tage
Muromonab-CD3 ~ Mariam T. Tennoe ~ 9786133024533
135,90 €
Kostenlos
135,90 €27,80 € teurer
Kostenloser Versand27,80 € teurer
rheinberg-buch-at · 99,9 % positiv (97.835)

Preise aktualisiert: 19. November 2026Diese Website nimmt am eBay Partner Network teil. Wir können eine Provision für qualifizierte Käufe erhalten, die über Links auf dieser Seite getätigt werden.

Preisverlauf

103 €105 €108 €110 €113 €12 Nov.14 Nov.16 Nov.19 Nov.

Spezifikationen

Marke
Betascript Publishing
EAN
9786133024533

Beschreibung

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Muromonab-CD3 (trade name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants. It is a monoclonal antibody targeted at the CD3 receptor, a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans. Muromonab-CD3 was approved by the U.S. Food and Drug Administration (FDA) in 1986, making it the first monoclonal antibody to be used as a drug for humans worldwide. In the European Communities, it was the first drug to be approved under the directive 87/22/EWG, a precursor of the European Medicines Agency (EMEA) centralised approval system in the European Union. This process included an assessment by the Committee for Proprietary Medicinal Products (CPMP, now CHMP), and a subsequent approval by the national health agencies; in Germany, for example, in 1988 by the Paul Ehrlich Institute in Frankfurt.

108,10 €
averdo.com
Angebot ansehen